S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
S&P 500   4,592.13 (+1.31%)
DOW   35,407.24 (+1.08%)
QQQ   371.96 (+1.50%)
AAPL   168.87 (+1.59%)
MSFT   309.69 (+2.10%)
FB   323.99 (+1.38%)
GOOGL   2,736.00 (+1.25%)
AMZN   3,126.58 (+0.02%)
TSLA   1,032.72 (+3.72%)
NVDA   252.74 (+0.83%)
BABA   133.58 (+4.57%)
NIO   30.42 (+6.25%)
AMD   127.48 (-0.62%)
CGC   7.95 (+4.06%)
MU   89.34 (-0.73%)
GE   101.01 (+0.39%)
T   27.33 (+0.18%)
F   22.36 (-0.40%)
DIS   151.17 (+0.71%)
AMC   19.54 (+6.66%)
PFE   54.00 (+0.86%)
ACB   5.00 (+2.88%)
BA   219.96 (+1.33%)
NASDAQ:MDRX

Allscripts Healthcare Solutions Stock Forecast, Price & News

$17.51
+0.40 (+2.34%)
(As of 01/20/2022 12:27 PM ET)
Add
Compare
Today's Range
$17.28
$17.58
50-Day Range
$15.89
$18.61
52-Week Range
$13.05
$19.00
Volume
28,411 shs
Average Volume
804,028 shs
Market Capitalization
$2.15 billion
P/E Ratio
3.40
Dividend Yield
N/A
Beta
1.04
30 days | 90 days | 365 days | Advanced Chart
Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.


Allscripts Healthcare Solutions logo

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segment. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Sector
Medical
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,400
Year Founded
1986

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$1.92 per share
Book Value
$10.55 per share

Profitability

Net Income
$700.41 million
Pretax Margin
-1.21%

Debt

Price-To-Earnings

Miscellaneous

Free Float
120,231,000
Market Cap
$2.15 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Today
1/20/2022
Next Earnings (Estimated)
2/24/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

1.80 out of 5 stars

Medical Sector

843rd out of 1,415 stocks

Computer Integrated Systems Design Industry

31st out of 47 stocks

Analyst Opinion: 1.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 1.3 5 -4 -3 -2 -1 -












Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

Is Allscripts Healthcare Solutions a buy right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Allscripts Healthcare Solutions stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View analyst ratings for Allscripts Healthcare Solutions
or view top-rated stocks.

How has Allscripts Healthcare Solutions' stock price been impacted by Coronavirus (COVID-19)?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MDRX stock has increased by 177.5% and is now trading at $17.51.
View which stocks have been most impacted by COVID-19
.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for Allscripts Healthcare Solutions
.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) posted its earnings results on Thursday, November, 4th. The software maker reported $0.27 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.18 by $0.09. The software maker earned $369 million during the quarter, compared to analyst estimates of $376.09 million. Allscripts Healthcare Solutions had a trailing twelve-month return on equity of 6.98% and a net margin of 51.74%. The firm's revenue was down 8.2% on a year-over-year basis. During the same quarter last year, the company earned $0.15 EPS.
View Allscripts Healthcare Solutions' earnings history
.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its Board of Directors has approved a stock buyback program on Wednesday, May 26th 2021, which authorizes the company to buyback $350,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 14% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its stock is undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.50 billion-$1.50 billion, compared to the consensus revenue estimate of $1.50 billion.

What price target have analysts set for MDRX?

7 brokers have issued twelve-month price objectives for Allscripts Healthcare Solutions' stock. Their forecasts range from $17.00 to $20.00. On average, they anticipate Allscripts Healthcare Solutions' stock price to reach $18.75 in the next twelve months. This suggests a possible upside of 7.1% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions
or view top-rated stocks among Wall Street analysts.

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:
  • Paul M. Black, Chief Executive Officer & Director (LinkedIn Profile)
  • Richard J. Poulton, President & Chief Financial Officer
  • Joseph R. Rostock, Chief Technology Officer & Senior VP-Development
  • Lisa Khorey, Chief Client Delivery Officer & Executive VP (LinkedIn Profile)
  • Eric Jacobson, Secretary & Senior Vice President

What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?

796 employees have rated Allscripts Healthcare Solutions CEO Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among Allscripts Healthcare Solutions' employees.

Who are some of Allscripts Healthcare Solutions' key competitors?

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.07%), Louisiana State Employees Retirement System (0.05%) and Crossmark Global Holdings Inc. (0.01%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black and Richard J Poulton.
View institutional ownership trends for Allscripts Healthcare Solutions
.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., State of Alaska Department of Revenue, and Louisiana State Employees Retirement System. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Lisa Khorey, Michael Klayko, Paul Black, and Richard J Poulton.
View insider buying and selling activity for Allscripts Healthcare Solutions
or view top insider-selling stocks.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $17.51.

How much money does Allscripts Healthcare Solutions make?

Allscripts Healthcare Solutions has a market capitalization of $2.15 billion and generates $1.50 billion in revenue each year. The software maker earns $700.41 million in net income (profit) each year or $5.15 on an earnings per share basis.

How many employees does Allscripts Healthcare Solutions have?

Allscripts Healthcare Solutions employs 8,400 workers across the globe.

Does Allscripts Healthcare Solutions have any subsidiaries?

The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.

When was Allscripts Healthcare Solutions founded?

Allscripts Healthcare Solutions was founded in 1986.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

Where are Allscripts Healthcare Solutions' headquarters?

Allscripts Healthcare Solutions is headquartered at 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at (800) 334-8534, via email at [email protected], or via fax at 313-322-9600.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.